PAPER Imamura K, Izumi Y, Egawa N, Ayaki T, Nagai M, Nishiyama K, Watanabe Y, Murakami T, Hanajima R, Kataoka H, Kiriyama T, Nanaura H, Sugie K, Hirayama T, Kano O, Nakamori M, Maruyama H, Haji S, Fujita K, Atsuta N, Tatebe H, Tokuda T, Takahashi N, Morinaga A, Tabuchi R, Oe M, Kobayashi M, Lobello K, Morita S, Sobue G, Takahashi R, Inoue H
SEARCH RESULTS
340304 RESULTS
PAPER Kouhi ZH, Seyedalipour B, Hosseinkhani S, Chaichi MJ
Bisdemethoxycurcumin, a novel potent polyphenolic compound, effectively inhibits the formation of amyloid aggregates in ALS-associated hSOD1 mutant (L38R).
Int J Biol Macromol. 2024 Oct 24;282(Pt 2):136701. PubMed.PAPER Khoodoruth MA, Khoodoruth WN, Uroos M, Al-Abdulla M, Khan YS, Mohammad F
Diagnostic and mechanistic roles of MicroRNAs in neurodevelopmental & neurodegenerative disorders.
Neurobiol Dis. 2024 Oct 24;:106717. PubMed.PAPER Godoy-Corchuelo JM, Ali Z, Brito Armas JM, Martins-Bach AB, García-Toledo I, Fernandez-Beltrán LC, Lopez-Carbonero JI, Bascunana P, Spring S, Jimenez-Coca I, Muñozde Bustillo Alfaro RA, Sanchez-Barrena MJ, Nair RR, Nieman BJ, Lerch JP, Miller KL, Ozdinler HP, Fisher EM, Cunningham TJ, Acevedo-Arozena A, Corrochano S
Corrigendum to "TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43" [Neurobiology of disease Volume 193, April 2024, 106437].
Neurobiol Dis. 2024 Oct 26;:106708. PubMed. Corrected paper.PAPER Pehar M, Hewitt M, Wagner A, Sandhu JK, Khalili A, Wang X, Cho JY, Sim VL, Kulka M
Histamine stimulates human microglia to alter cellular prion protein expression via the HRH2 histamine receptor.
Sci Rep. 2024 Oct 26;14(1):25519. PubMed.PAPER Zheng F, Dong T, Chen Y, Wang L, Peng G
Border-associated macrophages: From physiology to therapeutic targets in Alzheimer's disease.
Exp Neurol. 2024 Oct 24;:115021. PubMed.PAPER Rose EP, Banga JS, Unni VK
Polo-like kinase inhibition leads to neuroprotection of neurons bearing alpha-synuclein Lewy body-like inclusions in vivo.
MicroPubl Biol. 2024;2024 Epub 2024 Oct 10 PubMed.PAPER Liekniņa I, Reimer L, Panteļejevs T, Lends A, Jaudzems K, El-Turabi A, Gram H, Hammi A, Jensen PH, Tārs K
Structural basis of epitope recognition by anti-alpha-synuclein antibodies MJFR14-6-4-2.
NPJ Parkinsons Dis. 2024 Oct 27;10(1):206. PubMed.PAPER de Bruyn E, Dorn AE, Rossetti G, Fernandez C, Outeiro TF, Schulz JB, Carloni P
Impact of Phosphorylation on the Physiological Form of Human alpha-Synuclein in Aqueous Solution.
J Chem Inf Model. 2024 Oct 27; PubMed.PAPER O'Reilly S, Gouldson A, Wirth J, Cherbuin N, Eramudugolla R, Anstey KJ
Onset of cognitive impairment, diet quality and adherence to dietary guidelines over 12 years: the Personality and Total Health Cohort Study.
Br J Nutr. 2024 Oct 28;:1-8. PubMed.PAPER He Q, Zhang Z, Fu B, Chen J, Liu J
Changes in serum uric acid, glutathione, and amyloid-β1-42 levels in Parkinson's disease patients and their association with disease progression and cognitive decline.
Curr Med Res Opin. 2024 Oct 28;:1-15. PubMed.PAPER Seong SJ, Kim KW, Song JY, Park KJ, Jo YT, Han JH, Yoo KH, Jo HJ, Hwang JY
Inflammatory Cytokines and Cognition in Alzheimer's Disease and Its Prodrome.
Psychiatry Investig. 2024 Oct;21(10):1054-1064. Epub 2024 Oct 17 PubMed.PAPER Ren H, Feng Q, Chen L, Li L, Wang J, Wu J, Dong L, Liu T, Wang Z
Ten-words recall test: an effective tool to differentiate mild cognitive impairment from subjective cognitive decline.
Front Psychiatry. 2024;15:1429934. Epub 2024 Oct 11 PubMed.PAPER Holston EC
A Commentary: Invisibility of Older African-American Adults in Electrophysiological Research on Alzheimer's Disease.
Ethn Dis. 2024 Oct;34(4):181-184. Epub 2024 Oct 22 PubMed.PAPER Arrieta E, Baz P, García-Ribas G
FORTCARE-MCI study protocol: evaluation of Fortasyn Connect in the management of mild cognitive impairment in primary care.
Front Neurol. 2024;15:1434210. Epub 2024 Oct 3 PubMed.Current Filters
No filters selected